Close Menu

The Wall Street Journal has an article about using genomics to develop vaccines -- something that Novartis in particular has been developing. A vaccine for a certain form of meningitis, for instance, is showing promise in clinical trials and "Novartis plans to move [it] into a much-larger test involving thousands of children next year, says Rino Rappuoli, an Italian scientist who heads Novartis's vaccine research," according to the article.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.